Video

ESC 2017: The REVEAL Study - Randomized Placebo-Controlled Trial of Anacetrapib

Published: 15 Sep 2017

  • Views:

    Views Icon 160

  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Randomized Placebo-Controlled Trial of Anacetrapib in 30,449 Patients with Atherosclerotic Vascular Disease (REVEAL).

Filmed by Radcliffe Cardiology on-site at ESC 2017.